Riverain Technologies takes great lengths to remain active and vital in our industry. We hope we can meet you soon at a future event and remain connected through our latest posts, news releases, and social media.
The first FDA-cleared device that supports concurrent reading, allowing for faster reading with proven, superior, automatic nodule detection.
Our five FDA-cleared applications are designed to improve reading efficiency and accuracy across the hospital enterprise without additional equipment, procedures or radiation dose.
Riverain’s deep learning AI technology is FDA cleared, field tested, and clinically proven to provide real results in radiology.
Riverain Technologies advanced AI imaging software is in use by leading healthcare organizations around the world.
Peer reviews, reference accounts, and independent studies confirm that ClearRead technology is positively impacting the field of radiology.
Managing your lung program can seem daunting, whether you’re getting going, growing, or managing workflow. We’ve curated resources for you.
Riverain Technologies takes great lengths to remain active and vital in our industry. We hope we can meet you soon at a future event and remain connected through our latest posts, news releases, and social media.
Our technology is revolutionizing radiology. We’d love to work with you to help create better outcomes for patients everywhere.
